comparemela.com
Home
Live Updates
Johnson & Johnson Submits Guselkumab Application to FDA for Ulcerative Colitits : comparemela.com
Johnson & Johnson Submits Guselkumab Application to FDA for Ulcerative Colitits
The submission could grant guselkumab its third indication, after being approved by the FDA for psoriasis and psoriatic arthritis.
Related Keywords
Jessica Allegretti ,
David Lee ,
Walterk Jessica Allegretti ,
Kunzmannk Guselkumab ,
Drug Administration ,
Johnson ,
American College Of Gastroenterology ,
Biologics License Application ,
Disease Week ,
American College ,
Scientific Meeting ,
Quasar Study ,
Published May ,
Benefits Ulcerative Colitis Regardless ,
Patient Treatment ,
Published October ,
Fda ,
Guselkumab ,
Quasar ,
Ulcerative Colitis ,
Uc ,
Submission ,
Johnson Amp ,
comparemela.com © 2020. All Rights Reserved.